Nabriva Therapeutics PLC (NASDAQ:NBRV)

1.98
Delayed Data
As of Aug 23
 -0.09 / -4.35%
Today’s Change
1.12
Today|||52-Week Range
3.27
+35.62%
Year-to-Date

Today’s Trading

Previous close2.07
Today’s open2.07
Day’s range1.95 - 2.07
Volume2,174,965
Average volume (3 months)1,269,626
Market cap$143.8M
Data as of 4:00pm ET, 08/23/2019

Growth & Valuation

Earnings growth (last year)+9.25%
Earnings growth (this year)+51.07%
Earnings growth (next 5 years)-78.16%
Revenue growth (last year)+81.54%
P/E ratioNM
Price/Sales7.68
Price/Book1.91

Competitors

 Today’s
change
Today’s
% change
AXGTAxovant Gene Therapi...-0.34-5.03%
OSMTOsmotica Pharmaceuti...-0.22-7.28%
ACORAcorda Therapeutics ...-0.06-1.89%
IMUXImmunic Inc-0.44-3.09%
Data as of 4:00pm ET, 08/23/2019

Financials

Next reporting dateNovember 6, 2019
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$9.7M
Annual profit (last year)-$114.8M
Net profit margin-1,188.69%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Theodore R. Schroeder
President &
Chief Operating Officer
Steven P. Gelone
Corporate headquarters
Dublin, Dublin

Forecasts